// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Mast cell activation test, a novel approach for egg and cow's milk food allergy diagnosis in children

Bahri R - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Survey of young people and carers’ experience of undertaking pre‐adolescent peanut or tree nuts oral food challenges in secondary care setting, NHS, northern Ireland, UK in 2019

Curran L - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Epinephrine

Development and validation of a novel immunoassay for the quantification of the major celery allergen, Api g 1

Oliver MA - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Allergic reactions reported after negative double‐blind placebo‐controlled food challenges (DBPCFC) to milk and egg on the BAT 2 Study

Harrison FC - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A survey of perceived challenges faced by schools in East and North Hertfordshire regarding the management of anaphylaxis

Kilkelly B - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Anaphylaxis

N/A

A re‐audit of East and North Hertfordshire Schools’ policy on the management of anaphylaxis

Ha M - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Anaphylaxis

N/A

A dietetic led evaluation of patient satisfaction with the paediatric allergy service at a district general hospital, Northern Ireland, UK in 2018

Guy C - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Frey's syndrome in allergy clinic ‐ a case report

Aboobakuru AA - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Management of paediatric anaphylaxis in an NHS trust: Do we follow national guidelines and where are the gaps?

Dobson H - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Anaphylaxis

N/A

The investigation of children experiencing perioperative anaphylaxis in a tertiary UK hospital during a twelve month period

Marriage DE - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Anaphylaxis

N/A

Are we taking the right tests prior to walnut oral provocation challenges? Outcome analysis over a 2‐year period of children who underwent challenges at Bristol Royal Hospital for Children

Kanchanatheera M - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Significant improvement of allergy symptoms after probiotic food supplementation measured in an allergen exposure chamber

Bergmann KC - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Anaphylaxis education via simulation training in a tertiary paediatric A&E in the UK

Powell EA - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Anaphylaxis

Epinephrine

Knowledge, attitude and practices among patients and physicians on allergic rhinitis (KAPPA): An outcome of an international survey from 6 countries

Chua S - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Allergic rhinitis

N/A

Exploring parental understanding and views on topical corticosteroids (TCS) and TCS labelling in paediatric atopic dermatitis

Wilson F - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Atopic Dermatitis

N/A

Atopic keratoconjuctivitis: Is there any role for sublingual immunotherapy? A case report

Kakleas K - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Fluticasone furoate

A monoclonal antibody improves clinical symptom scores and quality of life in children with Th2 allergic inflammatory disease: The ADAGIO complex

Gainsborough FM - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Dupilumab

Self report assessment on severity of allergic rhinitis in relation to asthma control: A prospective cohort study

Lee R - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Allergic rhinitis

N/A

Food detectives: Quality of life, food allergen labelling and EU law

Romagosa Vilarnau S - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prospective study of home baked egg and nut introduction and its impact on children and their families

Andreou S - European Academy of Allergy and Clinical Immunology (EAACI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved